课题基金 / 基金详情

Research and Training to create assets in the form of new companies to develop a new model to generate innovative therapies

Research and Training to create assets in the form of new companies to develop a new model to generate innovative therapies
研究和培训以新公司的形式创建资产,开发新模式以产生创新疗法
批准号:
MR/W004291/1
负责人:
Anguraj Sadanandam
金额:
$10.77万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
已结题
起止时间:
2021 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer Research UK has partnered with Deep Science Ventures to create an opportunity for early career stage researchers to build ventures that target the complexity of biology. This partnership brings together the world's largest independent funder of cancer research with the unique venture design process of Deep Science Ventures to create a programme that is exhaustive in the search for the best approach from both technical and commercial perspectives, and positioned for new venture growth from day one. Their aim is to identify and bring together entrepreneurial scientists, academic advisors and investors to design and build new companies in oncology.In this project, the research goal is to develop therapies by leveraging the wealth of data of this new era to identify ways to kill cancer cells so that can escape from treatments. My role will be to start as a Founder Analyst within DeepScienceVentures under their unique framework for venture creation. It's a part-time role working mainly involving research. In order to make this research successful, I will apply my skills sets of machine learning/artificial intelligence, understanding heterogeneity, developing patient-based biomarkers and hands-on experience in preclinical trials. This also provides opportunity to get trained in market analysis, and customer development together with the DSV team before incorporating our own start-up.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金